BreezeBio
formerly GenEditBreezeBio is a biotech company in Brisbane, Australia, founded in 2016. It has raised $142.5M across 5 rounds, most recently a $60.0M Series B in February 2026.
BreezeBio
- Headquarters
- Brisbane
- Employees
- 51–200
- Founded
- 2016
- Business Model
- B2B
- Website
- breezebio.com
- Total Funding
- $142.5M
- Last Round
- $60.0M Series BFeb 2026
- Rounds
- 5
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 5 funding rounds and 14 investors for this company. The full record is or through the API.
About
BreezeBio is a biotechnology company developing precision genetic medicines enabled by targeted, non-viral delivery across biologically relevant tissues. Using its proprietary NanoGalaxy platform, the company engineers nanoparticles designed to deliver genetic payloads, including mRNA, to specific cell types, with demonstrated delivery to immune cells and tissues in the heart, lung, and central nervous system. BreezeBio is advancing an internal therapeutic pipeline focused on autoimmune disease and oncology, led by BRZ-101, a program designed to restore immune tolerance in Type 1 Diabetes that is advancing into IND-enabling studies.
Summary
It lists 51–200 employees. It has raised $142.5M in total across 5 rounds, most recently a $60.0M Series B round in Feb 2026. Investors include Eli Lilly, Yuanta Investment and DSC Investment.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Feb 2026
Sign up to see all 5 events
Funding: Seed through Series B. Amounts, valuations, and investors where available.
Investors
Eli Lilly
2 rounds
Yuanta Investment
1 round
DSC Investment
1 round
KTB Network
1 round
SK Holdings
1 round
KB Investment
2 rounds
IMM Investment
2 rounds
SV Investment
1 round
Kiwoom Investment
1 round
Dayli Financial Group
1 round
DCVC (Data Collab)
1 round
Company K Partners
1 round
Korea Investment Partners
1 round
DAYLI Partners
1 round
Similar Companies
Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/breezebio"><img src="https://indexed.vc/api/badge/company/breezebio" alt="BreezeBio on Indexed.vc" width="260" height="76" /></a>